Skip to content

Dressing Wear Time After Reduction Mammaplasty

Twenty-four Hours or 6 Days? A Prospective Randomized Trial Comparing Dressing Wear Time After Reduction Mammaplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01002391
Enrollment
70
Registered
2009-10-27
Start date
2009-02-28
Completion date
2010-09-30
Last updated
2019-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Colonization, Surgical Site Infection

Keywords

breast hypertrophy, mammaplasty, bandages, surgical site infection, skin colonization

Brief summary

This study was designed to determine whether the duration of dressing wear following reduction mammaplasty influence skin colonization and surgical site infections rates.

Detailed description

Surgical site infections (SSI) are wound infections that occur after invasive procedures.Particularly in plastic surgery procedures, to minimize the risk of SSI is imperative, since even minor infections are able to complicate the healing process and harm the cosmetic result. Reduction mammaplasty is an effective and well established procedure performed for the relief of physical pain and discomfort associated with macromastia, which significantly decreases patients' quality of life.Breast reduction has provided long-term relief for most patients, with high patient satisfaction. The demand for this kind of plastic surgery is high.Reduction mammaplasty was the fifth most commonly surgical procedure performed by plastic surgeons in women of United States.Since reduction mammaplasty is associated with a high incidence of wound problems,all effort to minimize the risk of SSI is valid.

Interventions

Dressing following reduction mammaplasty is removed on the first postoperative day

Sponsors

Universidade do Vale do Sapucai
CollaboratorOTHER
Daniela Francescato Veiga
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* breast hypertrophy * candidate to reduction mammaplasty * body mass index under 30Kg/m2

Exclusion criteria

* pregnancy, delivery or breast feeding during the last 12 months * body mass index over 30Kg/m2 * breast cancer history * previous breast surgery * hard smoking

Design outcomes

Primary

MeasureTime frame
surgical site infection30 days postoperatively

Secondary

MeasureTime frame
skin colonization6 days postoperatively

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026